Birgisson, H, Pahlman, L, Gunnarsson, U, Glimelius, B. Late adverse effects of radiation therapy for rectal cancer-a systematic overview. Acta Oncol
2007; 46 (4): 504–516.
Henson, C C, Burden, S, Davidson, S E, Lal, S. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. Cochrane Database Syst Rev 2013: 1–47.
Andreyev, J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance?
2005; 54 (8): 1051–1054.
Gami, B, Harrington, K, Blake, P
et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther
2003; 18 (10): 987–994.
McGough, C, Baldwin, C, Frost, G, Andreyev, H J N. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer
2004; 90 (12): 2278–2287.
Bentzen, S M, Baumann, M. Clinical manifestations of normal-tissue damage. In: Steel, G G (ed.) Basic Clinical Radiobiology. London: Hodder Arnold, 2002: 56–67.
Wouters, B G. Irradiation-induced damage and the DNA damage response. In: Steel, G G (ed.) Basic Clinical Radiobiology. London: Hodder Arnold, 2002: 27–40.
Del Fabbro, E, Demark-wahnefried, W, Baracos, V. Nutrition and the Cancer Patient. New York: Oxford University Press, 2010.
Beck, P L, Wong, J F, Li, Y
et al. Chemotherapy and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology
2004; 126 (3): 796–808.
Yeoh, E, Horowitz, M, Russo, A
et al. Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med
1993; 95 (4): 397–406.
Packey, C D, Ciorba, M A. Microbial influences on the small intestinal response to radiation injury. Curr Opin Gastroenterol
2010; 26: 88–94.
DeWitt, T, Hegazi, R. Nutrition in pelvic radiation disease and inflammatory bowel disease: similarities and differences. Biomed Res Int 2014: 1–6.
Henson, C C, Andreyev, H J N, Symonds, R P, Peel, D, Swindell, R, Davidson, S E. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists. Clin Oncol
2011; 23 (8): 552–557.
Webb, G J, Brooke, R, De Silva, A N. Chronic radiation enteritis and malnutrition. J Dig Dis
2013; 14 (7): 350–357.
Wedlake, L J, Shaw, C, Whelan, K, Andreyev, H J N. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther
2013; 37 (11): 1046–1056.
20.Great Britain. Data Protection Act. London: Stationery Office, 1998.
21.General Medical Council. Good medical practice. Manchester: General Medical Council, 2013.
Denscombe, M. The Good Research Guide for Small Scale Social Research Projects, 4th edition. Berkshire: Idea, 2010.
Henson, C. Optimising the management of gastrointestinal symptoms following pelvic radiotherapy. PhD, the University of Manchester, Manchester, 2014.
Jenkinson, C, Coulter, A, Bruster, S. The Picker Patient Experience Questionnaire: development and validation using data from in-patient surveys in five countries. Int J Qual Health Care
2002; 14 (5): 353–358.
Steine, S, Finset, A, Laerum, E. A new, brief questionnaire (PEQ) developed in primary health care for measuring patients’ experience of interaction, emotion and consultation outcome. Fam Pract
2001; 18 (4): 410–418.
Andreyev, H J N. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol
2007; 8 (11): 1007–1017.
Mitchell, E P. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol
2006; 33 (1): 106–120.
Dunberger, G, Lind, H, Steineck, G, Waldenström, A C, Onelöv, E, Avall-Lundqvist, E. Loose stools lead to fecal incontinence among gynecological cancer survivors. Acta Oncol
2011; 50 (2): 233–242.
Jakobsson, S, Ekman, T, Ahlberg, K. Living through pelvic radiotherapy: a mixed method study of self-care activities and distressful symptoms. Eur J Oncol Nurs
2014; 19 (3): 301–309.
Doyle, C, Kushi, L H, Byers, T
et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin
2006; 56 (6): 323–353.
Roberfroid, M. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr
1993; 33 (2): 103–148.
Murphy, J, Stacey, D, Crook, J, Thompson, B, Panetta, D. Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study. Can Oncol Nurs J
2000; 10 (3): 96–100.
Singh, B. Psyllium as therapeutic and drug delivery agent. Int J Pharm
2007; 334 (1): 1–14.
Hamer, H M, Jonkers, D M A E, Venema, K, Vanhoutvin, S A L W, Troost, F J, Brummer, R J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther
2008; 27 (2): 104–119.
Cook, S I, Selin, J H. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther
1998; 12: 449–507.
Wedlake, L, Thomas, K, McGough, C, Andreyev, H J N. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: an observational study. Eur J Cancer
2008; 44 (15): 2212–2217.
Shaw, C, Taylor, L. Treatment-related diarrhea in patients with cancer. Clin J Oncol Nurs
2012; 16 (4): 413–417.
Österlund, P, Ruotsalainen, T, Peuhkuri, K
et al. Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol
2004; 2 (8): 696–703.
Oates, R W, Schneider, M E, Lim Joon, M
et al. A randomised study of a diet intervention to maintain consistent rectal volume for patients receiving radical radiotherapy to the prostate. Acta Oncol
2014; 53 (4): 569–571.
Stubbe, C E, Valero, M. Complementary strategies for the management of radiation therapy side effects. J Adv Pract Oncol
2013; 4 (4): 219–231.
Andreyev, H J N. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol
2007; 19 (10): 790–799.